Japan Cancer Vaccines Market

The Japan cancer vaccines market consists of immunotherapies designed to prevent or treat cancer by activating the body's immune system. The primary customers are healthcare providers and pharmaceutical companies serving both adult and pediatric cancer patients. Key growth drivers for the market include the rising prevalence of cancer, increased government support for immunotherapy research, and significant advancements in biotechnology and personalized medicine.